• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对多发性硬化症中癌症发病率和流行率的系统评价。

A systematic review of the incidence and prevalence of cancer in multiple sclerosis.

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Mult Scler. 2015 Mar;21(3):294-304. doi: 10.1177/1352458514564489. Epub 2014 Dec 22.

DOI:10.1177/1352458514564489
PMID:25533302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4429168/
Abstract

BACKGROUND

Studies of cancer incidence and prevalence in multiple sclerosis (MS) have produced conflicting results.

OBJECTIVE

To estimate the incidence and prevalence of cancer in persons with MS and review the quality of included studies.

METHODS

We searched the PUBMED, SCOPUS, Web of Knowledge, and EMBASE databases, conference proceedings, and reference lists of all articles retrieved. Abstracts were screened for relevance by two reviewers. Data from included articles were captured using a standardized form, and the abstraction was verified by a second reviewer. We assessed quality of the included studies. We quantitatively assessed studies using the I (2) statistic, and conducted meta-analyses for population-based studies.

RESULTS

We identified 38 studies. Estimates for incidence and prevalence varied substantially for most cancers. In population-based studies, cervical, breast, and digestive cancers had the highest incidence. The risk of meningiomas and urinary system cancers appeared higher than expected, while the risks of pancreatic, ovarian, prostate and testicular cancer were lower than expected.

CONCLUSION

The complexity of understanding cancer risk in MS is augmented by inconsistencies in study design, and the relative paucity of age, sex and ethnicity-specific risk estimates from which the strong impact of age on the incidence of cancers can be assessed.

摘要

背景

多项多发性硬化症(MS)相关的癌症发病率和患病率研究结果相互矛盾。

目的

评估 MS 患者的癌症发病率和患病率,并对纳入研究的质量进行综述。

方法

我们检索了 PUBMED、SCOPUS、Web of Knowledge 和 EMBASE 数据库、会议记录以及检索到的所有文章的参考文献列表。两位评审员对摘要进行了相关性筛选。使用标准化表格捕获纳入文章的数据,并由第二位评审员验证提取内容。我们评估了纳入研究的质量。我们使用 I² 统计量对研究进行了定量评估,并对基于人群的研究进行了荟萃分析。

结果

我们共识别出 38 项研究。大多数癌症的发病率和患病率估计值差异很大。在基于人群的研究中,宫颈癌、乳腺癌和消化系统癌症的发病率最高。脑膜瘤和泌尿系统癌症的风险似乎高于预期,而胰腺癌、卵巢癌、前列腺癌和睾丸癌的风险则低于预期。

结论

由于研究设计的不一致性以及年龄、性别和种族特异性风险估计值相对较少,因此理解 MS 中癌症风险的复杂性增加了,而这些估计值可评估年龄对癌症发病率的强烈影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/45e71a70884d/10.1177_1352458514564489-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/f6f478ad9b22/10.1177_1352458514564489-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/b4f0d534dc81/10.1177_1352458514564489-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/6c39486e3005/10.1177_1352458514564489-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/9f07f36c1e02/10.1177_1352458514564489-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/45e71a70884d/10.1177_1352458514564489-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/f6f478ad9b22/10.1177_1352458514564489-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/b4f0d534dc81/10.1177_1352458514564489-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/6c39486e3005/10.1177_1352458514564489-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/9f07f36c1e02/10.1177_1352458514564489-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5d/4429168/45e71a70884d/10.1177_1352458514564489-fig5.jpg

相似文献

1
A systematic review of the incidence and prevalence of cancer in multiple sclerosis.对多发性硬化症中癌症发病率和流行率的系统评价。
Mult Scler. 2015 Mar;21(3):294-304. doi: 10.1177/1352458514564489. Epub 2014 Dec 22.
2
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
3
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.多发性硬化症中心境障碍的发病率和患病率:系统评价。
Mult Scler. 2015 Mar;21(3):305-17. doi: 10.1177/1352458514564487. Epub 2015 Jan 12.
4
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.一项关于多发性硬化症中心血管、脑血管和外周血管疾病的发病率和患病率的系统回顾。
Mult Scler. 2015 Mar;21(3):318-31. doi: 10.1177/1352458514564485. Epub 2014 Dec 22.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.一篇系统性综述:多发性硬化症中的自身免疫性疾病的发病率和流行率。
Mult Scler. 2015 Mar;21(3):282-93. doi: 10.1177/1352458514564490. Epub 2014 Dec 22.
7
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.多发性硬化症中并发胃肠道、肌肉骨骼、眼部、肺部和肾脏疾病的发病率和流行率:系统评价。
Mult Scler. 2015 Mar;21(3):332-41. doi: 10.1177/1352458514564488. Epub 2014 Dec 23.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.一项关于多发性硬化症中睡眠障碍和癫痫障碍发生率和流行率的系统回顾。
Mult Scler. 2015 Mar;21(3):342-9. doi: 10.1177/1352458514564486. Epub 2014 Dec 22.
10
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.

引用本文的文献

1
Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.多发性硬化症女性的妇科健康:低收入环境下巴氏试验的现状与结果概述。
PLoS One. 2025 Mar 28;20(3):e0320069. doi: 10.1371/journal.pone.0320069. eCollection 2025.
2
Cancer in multiple sclerosis patients following prolonged exposure to disease-modifying therapies (DMTs): a systematic review and meta-analysis.长期接触疾病修正疗法(DMTs)的多发性硬化症患者患癌情况:一项系统评价和荟萃分析
J Neurol. 2025 Jan 23;272(2):162. doi: 10.1007/s00415-024-12882-4.
3
Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study.

本文引用的文献

1
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
2
Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.炎症性肠病患者的恶性肿瘤:芬兰一项全国性登记研究
Scand J Gastroenterol. 2013 Dec;48(12):1405-13. doi: 10.3109/00365521.2013.846402. Epub 2013 Oct 16.
3
Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study.
多发性硬化症的恶性肿瘤风险及疾病修正治疗的应用:在一项多中心研究中探索疾病修正治疗的作用。
Front Neurol. 2024 Dec 13;15:1492678. doi: 10.3389/fneur.2024.1492678. eCollection 2024.
4
Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.多发性硬化症患者的癌症和死亡率风险:伊朗伊斯法罕的一项基于人群的研究。
PLoS One. 2024 Oct 31;19(10):e0312707. doi: 10.1371/journal.pone.0312707. eCollection 2024.
5
Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies.与多发性硬化症的疾病修正治疗相关的癌症发展风险:系统评价和随机及非随机研究荟萃分析的研究方案。
Syst Rev. 2024 Oct 18;13(1):263. doi: 10.1186/s13643-024-02677-z.
6
Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.多发性硬化症患者的癌症风险:一项为期 10 年的全国回顾性队列研究。
Neurology. 2024 Nov 12;103(9):e209885. doi: 10.1212/WNL.0000000000209885. Epub 2024 Oct 9.
7
An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study.一项基于孟德尔随机化研究的九种神经退行性疾病与乳腺癌风险之间因果关系的探索。
Aging (Albany NY). 2024 Apr 24;16(8):7101-7118. doi: 10.18632/aging.205745.
8
[Comorbidities in multiple sclerosis and their influence on the choice of treatment].[多发性硬化症的合并症及其对治疗选择的影响]
Rev Neurol. 2024 Mar 16;78(6):157-170. doi: 10.33588/rn.7806.2023277.
9
Case report: Diagnostic challenge: a new multiple sclerosis "relapse" leading to the diagnosis of anaplastic astrocytoma.病例报告:诊断挑战:一例导致间变性星形细胞瘤诊断的新型多发性硬化“复发”。
Front Neurol. 2024 Jan 26;14:1324269. doi: 10.3389/fneur.2023.1324269. eCollection 2023.
10
Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study.老年多发性硬化症患者的合并症:一项丹麦全国性研究。
Front Neurol. 2023 Nov 24;14:1297709. doi: 10.3389/fneur.2023.1297709. eCollection 2023.
多发性硬化症患者患乳腺癌风险增加:一项基于全国人口的队列研究。
Eur J Neurol. 2014 Feb;21(2):238-44. doi: 10.1111/ene.12267. Epub 2013 Sep 19.
4
Cancer risk in immune-mediated inflammatory diseases (IMID).免疫介导的炎症性疾病(IMID)中的癌症风险。
Mol Cancer. 2013 Aug 29;12(1):98. doi: 10.1186/1476-4598-12-98.
5
Subsequent brain tumors in patients with autoimmune disease.自身免疫性疾病患者的后继脑肿瘤。
Neuro Oncol. 2013 Sep;15(9):1142-50. doi: 10.1093/neuonc/not070. Epub 2013 Jun 11.
6
Subsequent leukaemia in autoimmune disease patients.自身免疫性疾病患者的继发白血病。
Br J Haematol. 2013 Jun;161(5):677-687. doi: 10.1111/bjh.12330. Epub 2013 Apr 9.
7
Cancer risk in systemic lupus: an updated international multi-centre cohort study.系统性红斑狼疮的癌症风险:一项更新的国际多中心队列研究。
J Autoimmun. 2013 May;42:130-5. doi: 10.1016/j.jaut.2012.12.009. Epub 2013 Feb 12.
8
Incidence and prevalence of multiple sclerosis in the Americas: a systematic review.美洲多发性硬化症的发病率和患病率:系统评价。
Neuroepidemiology. 2013;40(3):195-210. doi: 10.1159/000342779. Epub 2013 Jan 24.
9
Autoimmune disease and subsequent urological cancer.自身免疫性疾病与随后发生的泌尿系统癌症。
J Urol. 2013 Jun;189(6):2262-8. doi: 10.1016/j.juro.2012.12.014. Epub 2012 Dec 8.
10
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma.自身免疫性疾病对后续多发性骨髓瘤发病和生存的影响。
J Hematol Oncol. 2012 Oct 2;5:59. doi: 10.1186/1756-8722-5-59.